CHRNG
protein-codingcholinergic receptor nicotinic gamma subunit, the group of Cholinergic receptors nicotinic subunits
Gene summary
The mammalian muscle-type acetylcholine receptor is a transmembrane pentameric glycoprotein with two alpha subunits, one beta, one delta, and one epsilon (in adult skeletal muscle) or gamma (in fetal and denervated muscle) subunit. This gene, which encodes the gamma subunit, is expressed prior to the thirty-third week of gestation in humans. The gamma subunit of the acetylcholine receptor plays a role in neuromuscular organogenesis and ligand binding and disruption of gamma subunit expression prevents the correct localization of the receptor in cell membranes. Mutations in this gene cause Escobar syndrome and a lethal form of multiple pterygium syndrome. Muscle-type acetylcholine receptor is the major antigen in the autoimmune disease myasthenia gravis.[provided by RefSeq, Sep 2009]
- ACHRG
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0018326
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009668
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009926
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0100158
Submitter: ClinGen
Cholinergic Receptor, Nicotinic, Gamma Polypeptide (CHRNG; MIM#100730) is the gamma subunit of the Acetylcholine receptor (AChR). CHRNG is the variable subunit of AChR, which is present in humans before 33 weeks of gestational age and replaced by the 𝜀 subunit (CHRNE; MIM#100725) in late fetal and perinatal period. Fetal AChR is critical for establishing muscle-axon interface and neuromuscular junctions as well as prenatal neuromuscular signal transduction. Biallelic pathogenic variants in CHRNG are associated with CHRNG-associated hypo-akinesia disorder of prenatal onset (MONDO:0100158) with autosomal recessive inheritance pattern. Clinical phenotypes are variable include prenatal akinesia and associated resulting phenotypes, pterygium, poly- or oligohydramnios, intrauterine growth restriction, cystic hygroma, hydrops, reduced fetal movements, muscle weakness, congenital contractures, and fetal demise or stillbirth. The molecular etiology of CHRNG-associated disease was first reported by Hoffmann (2006; PMID:16826520) and Morgan (2006; PMID:16826531), and since has been reported in many additional male and female probands and found to segregate with disease in families and genetic evidence was scored at the maximum of 12 points [PMIDs:16826520, 16826531, 30868735, 34440395]. Functional evidence including expression studies [PMID:18252226, 16826520] and a mouse model recapitulating the observed human phenotype [PMID:12101101] were scored for an additional 3.0 points. Given this and its replication in the literature over time, the association of CHRNG with CHRNG-associated hypo-akinesia disorder of prenatal onset is curated as Definitive by the Prenatal Gene Curation Expert Panel.
Inheritance Pattern: AR
Disease ID:MONDO:0009668
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009926
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009926
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CHRNG variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005199.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 157 | 159 | |||
| missense | 2 | 6 | 109 | 16 | 1 | 134 |
| nonsense | 13 | 12 | 25 | |||
| start loss | 1 | 1 | ||||
| frameshift | 18 | 12 | 1 | 31 | ||
| splice donor/acceptor (+/-2bp) | 2 | 19 | 21 | |||
| Total | 35 | 50 | 112 | 173 | 1 | 371 |
Highest pathogenic variant AF is 0.0007217913
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005190.4 | 12 | MANE Select | |
| Ensembl | ENSP00000498757.1 | 12 | MANE Select | |
| Ensembl | ENSP00000374143.3 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neuroactive ligand-receptor interaction - Homo sapiens (human)
- Highly sodium permeable acetylcholine nicotinic receptors
- Neuronal System
- role of nicotinic acetylcholine receptors in the regulation of apoptosis
- Neurotransmitter receptors and postsynaptic signal transmission
Biological Process
- muscle contraction
- signal transduction
- chemical synaptic transmission
- synaptic transmission, cholinergic
- neuromuscular synaptic transmission
Molecular Function
- extracellular ligand-gated ion channel activity
- protein binding
- channel activity
- acetylcholine receptor activity
- acetylcholine-gated cation-selective channel activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- acetylcholine-gated channel complex
- cell junction
- neuron projection
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000389494
- Coding exons
- 12
- Length
- 6677
- Individuals with no LoFs
- 125488
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 260
- Defined
- 125748
- p
- 0.00103
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.118 | 310 | 304 | 1.02 | 0.0000209 | 3325 |
| Missense (PolyPhen) | 110 | 121.31 | 0.9068 | 1437 | ||
| Synonymous | 0.0280 | 135 | 135 | 0.997 | 0.00000963 | 1101 |
| Loss of Function | 0.177 | 29 | 30.0 | 0.965 | 0.00000187 | 275 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.00087 | 0.00087 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00087 | 0.00087 | rare |
| Finnish | 0.00079 | 0.00079 | rare |
| European (Non-Finnish) | 0.0012 | 0.0012 | notable |
| South Asian | 0.0012 | 0.0010 | notable |
| Other | 0.0015 | 0.0015 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.;
- Disease
- DISEASE: Multiple pterygium syndrome, lethal type (LMPS) [MIM:253290]: Multiple pterygia are found infrequently in children with arthrogryposis and in fetuses with fetal akinesia syndrome. In lethal multiple pterygium syndrome there is intrauterine growth retardation, multiple pterygia, and flexion contractures causing severe arthrogryposis and fetal akinesia. Subcutaneous edema can be severe, causing fetal hydrops with cystic hygroma and lung hypoplasia. Oligohydramnios and facial anomalies are frequent. {ECO:0000269|PubMed:16826520, ECO:0000269|PubMed:16826531}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple pterygium syndrome, Escobar variant (EVMPS) [MIM:265000]: Non-lethal form of arthrogryposis multiplex congenita. It is an autosomal recessive condition characterized by excessive webbing (pterygia), congenital contractures (arthrogryposis), and scoliosis. Variable other features include intrauterine death, congenital respiratory distress, short stature, faciocranial dysmorphism, ptosis, low-set ears, arachnodactyly and cryptorchism in males. Congenital contractures are common and may be caused by reduced fetal movements at sensitive times of development. Possible causes of decreased fetal mobility include space constraints such as oligohydramnion, drugs, metabolic conditions or neuromuscular disorders including myasthenia gravis. {ECO:0000269|PubMed:16826520, ECO:0000269|PubMed:16826531}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0850
Intolerance Scores
- LoFtool
- 0.308
- RVIS EVS
- -0.42
- RVIS percentile EVS
- 25.79
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.616
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |